Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Human Genome Exhibition Makes DNA Accessible to Public

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
Unique NIH-Smithsonian collaboration unlocks the present and future of genome science.

The Smithsonian Institution's first exhibition about genome science, Genome: Unlocking Life's Code, opens Friday, June 14, 2013, at the National Museum of Natural History in partnership with the National Human Genome Research Institute (NHGRI), a part of the National Institutes of Health.

The exhibition examines the complexities of the genome - the complete set of genetic or hereditary material of a living organism - and chronicles the remarkable breakthroughs that have taken place since the completion of the Human Genome Project a decade ago.

With cutting-edge interactives, 3D models, custom animations and engaging videos of real-life stories, the exhibition examines both the benefits and the challenges that genomics presents to modern society.

"This exhibition reflects a remarkably productive collaboration between components of two scientific icons of the U.S. government- the Smithsonian Institution and the National Institutes of Health," said Eric D. Green, M.D., Ph.D., director of NHGRI, one of the 27 institutes and centers that make up NIH.

Green continued, "Our ability to showcase the science of genomics to the roughly 7 million annual visitors of the National Museum of Natural History is profoundly exciting for the broader genomics research community."

The exhibition's opening celebrates the anniversaries of two landmark scientific discoveries: the 10th anniversary of the Human Genome Project's completion and the 60th anniversary of Drs. James Watson's and Francis Crick's discovery of DNA's double-helical structure. It will be open at the National Museum of Natural History through September 2014, after which the exhibition will travel throughout North America for about five years.

"Genomic research is a vital tool for exploring the mysteries of the natural world and it is an important part of Smithsonian science," said Kirk Johnson, the Sant Director of the National Museum of Natural History. "Genome: Unlocking Life's Code will help our visitors understand how genomics is transforming what we know about ourselves and how we make important life decisions."

From the moment visitors enter the approximately 2,900 square-foot exhibition, they will find themselves immersed in an interactive, futuristic environment that communicates the revolutionary nature of genomics.

The exhibition gives visitors a window into genomes that provides new ways of looking at themselves as individuals, as members of a family and a species, and as part of the diversity of life on Earth.

Genome: Unlocking Life's Code is organized around three content areas offering visitors personalized and interactive experiences that explore what a genome is (The Genome Within Us), how it relates to medicine and health (Your Genome, Your Health), and how it connects humans to all of life on the planet (Connections: Natural World and Genomic Journey).

Within each gallery, numerous topics are explored through the latest imagery on genomics, hands-on and media interactives, videos and other engaging content. Through examples of ways that genome science can affect their lives in ordinary and extraordinary ways, visitors will also come to learn how genomics can affect perspectives about health, identity, and the place of humans in the natural world.

Genome: Unlocking Life's Code will take visitors on a genomic journey from the present to the future:

The Genome Within Us: Upon arrival, museum-goers will be oriented at the center of the exhibition where they will explore how the genome is a part of their own bodies. Visitors will discover what a genome is, where it is located in the human body (in the cell nucleus), and how it works to regulate life, through introductory videos produced by the History channel. Visitors will see three-dimensional models of a human genome and watch interviews with Human Genome Project researchers.

Visitors can also participate in a social media interactive where they can explore the ethical, legal, and social implications of advancing DNA sequencing technologies, submit their responses on an interactive station and find out how their views compare with those of other visitors. An electronic news ticker display will provide an ongoing stream of recent developments in genomics.

Your Genome, Your Health: Guests can explore the many ways in which genome sequencing benefits patients through improved health care. They can learn about genes, genomic solutions to mysterious medical diseases, and, through a futuristic DNA interactive, search for the right medicine for a given disease. An interactive puzzle allows visitors to learn how genetic, environmental, and random factors influence risk for a particular disease.

Connections: Natural World and Genomic Journey: Visitors will learn about the ways that genomes reflect the connection of all life on the planet, human ancestry and evolution - and even human society. There will be an opportunity to learn more about how the Smithsonian is using new genomic technologies to preserve genetic diversity and study changes in our environment through the Global Genome Initiative and GGI's growing biorepository.

"Today, the Smithsonian is a leader in utilizing genomic research to understand the diversity of life on earth," said Jonathan Coddington, Ph.D., associate director for science at the National Museum of Natural History. "This exhibition provides a unique opportunity to showcase the cutting edge biotechnological research going on behind-the-scenes at the museum, and features some of our scientists' work on hot topics like bird strikes, butterflies, wine grapes, bio-coding, Tasmanian devils and the Global Genome Initiative. Thanks to genomics, we now have the tools to sequence every organism on the planet, allowing us to preserve genetic diversity, study changes in our environment and learn more about how these changes affect all life on earth."

In addition to the exhibition, a special educational website, Unlocking Life's Code (http://unlockinglifescode.org), was created to support the exhibition and provide additional educational materials beyond the walls of the museum. A program of ongoing educational events in Washington, D.C., is also being developed and will be announced on the website.

"Collaborating with the Smithsonian National Museum of Natural History in the development of the genome exhibition created an opportunity to educate the public about advances in genomics research" said Vence L. Bonham, Jr., J.D., chief of the education branch in NHGRI's Division of Policy, Communications and Education. "NHGRI engages communities across the country to explore genomics and health, but this is the first collaboration with the Smithsonian Institution, which will reach millions of visitors at the National Museum of Natural History."

The exhibition was made possible through the generous support of the Life Technologies Foundation, and other important sponsors, including Johnson & Johnson, Ancestry.com and The Brin Wojcicki Foundation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
Tuesday, July 21, 2015
NIH Study Identifies Gene Variant Linked to Compulsive Drinking
Mice carrying the Met68BDNF gene variant would consume excessive amounts of alcohol.
Tuesday, July 21, 2015
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Friday, July 03, 2015
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Thursday, July 02, 2015
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Tuesday, June 09, 2015
A New Role for Zebrafish: Larger Scale Gene Function Studies
A relatively new method of targeting specific DNA sequences in zebrafish could dramatically accelerate the discovery of gene function and the identification of disease genes in humans.
Monday, June 08, 2015
NIH Researchers Pilot Predictive Medicine by Studying Healthy People’s DNA
New study sequence the genomes of healthy participants to find “putative,” or presumed, mutations.
Friday, June 05, 2015
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
Wednesday, June 03, 2015
Scientists Create Mice with a Major Genetic Cause of ALS and FTD
NIH-funded study provides new platform for testing treatments for several neurodegenerative disorders.
Friday, May 22, 2015
Mice With a Major Genetic Cause of ALS and FTD Created
NIH-funded study provides new platform for testing treatments for several neurodegenerative disorders.
Thursday, May 21, 2015
New Insights into How DNA Differences Influence Gene Activity, Disease Susceptibility
NIH-funded pilot study provides a new resource about variants across the human genome.
Friday, May 08, 2015
Souped-up Remote Control Switches Behaviors On-and-Off in Mice
BRAIN Initiative yields chemical-genetic tool with push-pull capabilities.
Thursday, May 07, 2015
NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy
Benefits for Leber congenital amaurosis peak after one to three years, then diminish.
Tuesday, May 05, 2015
Possible Treatment for Lethal Pediatric Brain Cancer
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
Tuesday, May 05, 2015
Statement on NIH Funding of Research Using Gene-Editing Technologies in Human Embryos
Researchers modify the gene responsible for a potentially fatal blood disorder using CRISPR/Cas9 technology.
Saturday, May 02, 2015
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!